EMERYVILLE, Calif., Feb. 08, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT; 4DMT or the Company), a leading clinical-stage company...
Read moreDetailsAMD (AMD -2.36%) continues delivering revenue and profit growth, but the stock price is not reacting positively.
Read moreDetailsAdvanced Micro Devices (AMD -2.36%) shares fell following its Q4 earnings report as its data center revenue soared but still...
Read moreDetailsIn today's video, I discuss Advanced Micro Devices (AMD -1.65%) and its recently reported earnings. To learn more, check out...
Read moreDetailsAMD's (AMD -1.65%) data center growth failed to impress investors.
Read moreDetailsHere's our initial take on Advanced Micro Devices' (AMD 4.58%) fourth-quarter financial report.
Read moreDetailsAdvanced Micro Devices Inc (NASDAQ: AMD) is taking a hit in after-hours on Tuesday despite reporting market-beating financial results for...
Read moreDetailsMelius Research analyst Ben Reitzes downgraded Advanced Micro Devices AMD from Buy to Hold and lowered the price target from $160 to $129.
Read moreDetailsThe artificial intelligence (AI) revolution is firmly upon us, and investors everywhere are scrambling to gain exposure to companies heavily...
Read moreDetailsIn the early days of the artificial intelligence (AI) infrastructure build-out, graphic processing units (GPUs) have been the go-to chips...
Read moreDetailsThis website automatically aggregates content from various other websites. The copyright of content and images belongs to those websites and their respective companies. We are not responsible for the content published here. Please ensure that all information is for reference only and not investment advice. However, we will strive to strictly control content that provides no value or brings negativity to the community.
© 2025 financialat.com